The Valley Desk

NCT04425629 · Interventional trial

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Overall registry status Terminated

Phase 3

Conditions COVID-19

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov